Abstracts of the 8th ESC Congress Edinburgh 2004

Copyright 2004 Taylor & Francis Limited. All rights reserved

STATE OF THE ART FREE COMMUNICATIONS POSTERS
KEYNOTE SESSIONS WORKSHOPS SPONSORED SYMPOSIA
Symposium 1: New trends in European contraception
Symposium 2: The Vagina Dialogue: NuvaRing® and the benefits of vaginal administration
Symposium 3: Customizing care… The art and science of low dose OC prescribing
Symposium 4: Estrogen-free contraception: the evolution of depot medroxyprogesterone acetate
Symposium 5: Contraception: why change?
Symposium 1: New trends in European contraception (Schering)
Contraceptive use in European women: a research survey on contemporary behaviour S. Skouby (Denmark) Abstract
Long-term contraception in young women: special focus on nulliparous women and contraception following abortion A. Gebbie (UK) Abstract
Contraception as a therapeutic option in the treatment of menorrhagia H. Critchley (UK) Abstract
The non-contraceptive benefits and acceptability of Yasmin® D. Mansour(UK) Abstract
Yasmin® and the extended cycle regimen: current experience M. Sillem (Germany) Abstract
Symposium 2: The Vagina Dialogue: NuvaRing® and the benefits of vaginal administration (Organon)
Women and their vaginas G. Liekens (Belgium) no abstract
The clinical profile of NuvaRing, update on new results S. Killick (UK) no abstract
NuvaRing and the beauty of vaginal administration R. Arias (United States) no abstract
Symposium 3: Customizing care… The art and science of low dose OC prescribing (Wyeth Pharmaceuticals)
Oral contraceptive side effects: impact of estrogen dose when selecting an oral contraceptive P. Darney Abstract
Acceptability, safety and premenstrual symptomatology in women using an oral contraceptive containing gestodene 60mcg/ethinylestradiol 15mcg I. Barbosa Abstract
Symposium 4: Estrogen-free contraception: the evolution of depot medroxyprogesterone acetate (Pfizer)
Hormonal contraception without estrogen: nondaily options A. Glasier (UK) no abstract
Expanding low-dose options in contraception C. Brucker (Germany) no abstract
Maximizing contraceptive convenience: managing expectations I. Milsom (Sweden) no abstract
Symposium 5: Contraception: why change? (Janssen-Cilag)
Contraception: are we keeping up? M. O'Flynn (Rep. of Ireland) no abstract
The transdermal route: what is it delivering? C. Keck (Germany) no abstract
Where do we go from here? J. Guillebaud (UK) no abstract

 

home